CIBC World Market’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.67M Sell
33,360
-241
-0.7% -$19.9K ﹤0.01% 699
2025
Q4
$2.86M Buy
33,601
+9,120
+37% +$748K ﹤0.01% 695
2025
Q3
$1.9M Buy
24,481
+1,695
+7% +$132K ﹤0.01% 806
2025
Q2
$1.78M Sell
22,786
-1,546
-6% -$115K ﹤0.01% 767
2025
Q1
$1.76M Sell
24,332
-1,189
-5% -$85.1K ﹤0.01% 747
2024
Q4
$1.89M Buy
25,521
+10,935
+75% +$765K ﹤0.01% 736
2024
Q3
$963K Sell
14,586
-21,736
-60% -$1.58M ﹤0.01% 840
2024
Q2
$3.35M Sell
36,322
-895
-2% -$79.3K 0.01% 536
2024
Q1
$3.56M Buy
37,217
+17,453
+88% +$1.47M 0.01% 529
2023
Q4
$1.51M Buy
19,764
+649
+3% +$45.2K ﹤0.01% 676
2023
Q3
$1.32M Sell
19,115
-37,776
-66% -$3.04M ﹤0.01% 670
2023
Q2
$5.37M Buy
56,891
+41,951
+281% +$3.65M 0.02% 362
2023
Q1
$1.24M Buy
14,940
+696
+5% +$54.7K ﹤0.01% 702
2022
Q4
$1.06M Sell
14,244
-2,858
-17% -$220K ﹤0.01% 744
2022
Q3
$1.41M Sell
17,102
-607
-3% -$58.4K 0.01% 641
2022
Q2
$1.68M Sell
17,709
-25,635
-59% -$2.65M 0.01% 600
2022
Q1
$5.1M Sell
43,344
-7,964
-16% -$893K 0.02% 368
2021
Q4
$6.65M Sell
51,308
-30,082
-37% -$3.51M 0.02% 333
2021
Q3
$9.21M Sell
81,390
-31,141
-28% -$3.55M 0.03% 254
2021
Q2
$11.7M Buy
112,531
+52,105
+86% +$4.91M 0.03% 231
2021
Q1
$5.05M Buy
60,426
+224
+0.4% +$18.9K 0.01% 369
2020
Q4
$5.49M Sell
60,202
-16,764
-22% -$1.39M 0.02% 340
2020
Q3
$6.14M Buy
76,966
+4,071
+6% +$318K 0.03% 265
2020
Q2
$5.04M Sell
72,895
-9,320
-11% -$662K 0.02% 284
2020
Q1
$5.17M Buy
82,215
+39,558
+93% +$2.85M 0.03% 241
2019
Q4
$3.32M Sell
42,657
-36,153
-46% -$2.82M 0.01% 394
2019
Q3
$5.78M Buy
78,810
+57,681
+273% +$4.05M 0.03% 277
2019
Q2
$1.3M Sell
21,129
-83,172
-80% -$5.03M 0.01% 581
2019
Q1
$6.65M Buy
104,301
+61,791
+145% +$3.53M 0.03% 244
2018
Q4
$2.17M Buy
42,510
+29,700
+232% +$1.5M 0.01% 421
2018
Q3
$743K Sell
12,810
-68,862
-84% -$3.37M ﹤0.01% 771
2018
Q2
$3.96M Buy
81,672
+11,487
+16% +$536K 0.02% 338
2018
Q1
$3.26M Buy
70,185
+64,335
+1,100% +$2.79M 0.01% 357
2017
Q4
$220K Sell
5,850
-1,209
-17% -$44.4K ﹤0.01% 739
2017
Q3
$257K Sell
7,059
-27,408
-80% -$1.05M ﹤0.01% 669
2017
Q2
$1.36M Buy
34,467
+11,451
+50% +$418K 0.01% 566
2017
Q1
$722K Sell
23,016
-58,218
-72% -$1.82M ﹤0.01% 656
2016
Q4
$2.54M Sell
81,234
-145,860
-64% -$4.73M 0.01% 373
2016
Q3
$9.13M Buy
227,094
+109,761
+94% +$4.13M 0.03% 140
2016
Q2
$3.9M Buy
117,333
+64,569
+122% +$2.21M 0.02% 216
2016
Q1
$1.55M Sell
52,764
-117,765
-69% -$3.25M 0.01% 354
2015
Q4
$4.49M Buy
+170,529
New +$4.43M 0.02% 201
2015
Q1
Sell
-133,596
Closed -$2.84M 845
2014
Q4
$2.84M Buy
+133,596
New +$2.68M 0.01% 263

Other funds holding EW

CIBC World Market's EW Position: Q1 2026 in Review

CIBC World Market reduced its Edwards Lifesciences (EW) stake by 0.72% in Q1 2026, selling an estimated $19.9K and leaving 33,360 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #699.

CIBC World Market first reported a position in EW in Q4 2014 and has held it in 43 quarters since. The position peaked at $11.7M in Q2 2021. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • CIBC World Market held 33,360 shares of Edwards Lifesciences worth $2.67M as of Q1 2026.
  • CIBC World Market sold 241 Edwards Lifesciences shares in Q1 2026, an estimated $19.9K.
  • Edwards Lifesciences made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #699 holding.
  • CIBC World Market first reported a position in Edwards Lifesciences in Q4 2014 and has held it in 43 quarters since.
  • CIBC World Market's Edwards Lifesciences position peaked at $11.7M in Q2 2021.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.